Objective: To document changes in the prevalence of resistance of Prop
ionibacterium acnes to antibiotics used for treating acne. Data source
s: MEDLINE and EMBASE were searched for publications on P. acnes resis
tance to systemic antibiotics. The search strategy mapped ''acne'' or
''acne vulgaris'' with the terms ''antibiotic resistance'' or ''drug r
esistance, microbial''. Only papers published in English during 1976 t
o 1997 were included in the search. Study selection: 53 publications m
et the search criteria. The search output was refined by selecting pap
ers that specifically addressed P. acnes resistance patterns. Addition
al studies (not included in the search output) were identified from re
view articles and references of the retrieved articles. Twelve article
s were reviewed. Data extraction: Data on the prevalence of antibiotic
-resistant propionibacteria, the incidence of individual resistance ph
enotypes, mixed resistance, and correlation between poor therapeutic r
esponse and resistant propionibacteria were extracted. Data synthesis:
Research since 1978 has suggested an association between poor therape
utic response and antibiotic-resistant propionibacteria. The overall i
ncidence of P. acnes antibiotic resistance has increased from 20% in 1
978 to 62% in 1996. Resistance to specific antibiotics varied and was
most commonly reported with erythromycin and clindamycin, tetracycline
and doxcycline, and trimethoprim. Resistance to minocycline is rare.
Conclusions: In many patients with acne, continued treatment with anti
biotics can be inappropriate or ineffective. It is important to recogn
ise therapeutic failure and alter treatment accordingly. The use of lo
ng-term rotational antibiotics is outdated and will only exacerbate an
tibiotic resistance.